Scientific Advisors

Dr. Peter K. Vogt
Professor, Dept. of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA

Dr. Vogt research is on mechanisms of cancer. He served as a scientific advisor to both Microgenics and Calydon. He is a member of the National Academy of Sciences.

 

Sir John Skehel FRS FMedSci
Secretary, Biological Sciences Division, Royal Society of London

Sir John Skehel FRS FMedSci was Director of the National Institute for Medical Research (UK) from 1987 to 2006, Director of the WHO World Influenza Centre from 1975 to 1993, and currently is Secretary, Biological Sciences Division, Royal Society of London.  His research is on the structure and functions of the influenza virus hemagglutinin (HA) and neuraminidase (NA) membrane glycoproteins. He is a member of the National Academy of Sciences. 

 

Dr. Peter A. Barry
Director, Center for Comparative Medicine, University of California, Davis

Dr. Barry was Director of the California National Primate Research Center at Davis. His research is on mechanisms of cytomegalovirus (CMV) persistence and pathogenesis, as well as human CMV vaccine strategies as tested in non-human primate models.

 

Dr. Steve F. Dowdy
Professor, Cellular and Molecular Medicine, University of California, San Diego, School of Medicine

Dr. Dowdy research interests include mechanisms of G1 cell cycle progression, macromolecular drug delivery using TAT Peptide Transduction Domains, mRNA replicons, RNAi and a class of RNAi pro drugs known as RiboNucleic Neutrals (RNN).

 

Dr. John H. Crowe
Professor of Molecular and Cellular Biology, Emeritus and Director of the Center for Biostabilization Emeritus at UC Davis.

Dr. Crowe is well known for work on stabilization of biomaterials in the frozen and dry states, with many applications in pharmacy and clinical medicine, and he holds, with the University of California, numerous patents in this field.  He is a Fellow of the American Association for the Advancement for Science, Fellow of the Society for Cryobiology, Fulbright Senior Research Scholar, Guggenheim Fellow, and serves on numerous editorial boards for scientific journals. His work was recently featured on NPR’s Science Friday

 

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. Jan A. Van Prooyen
Non-Executive Chairman of the Board

Jan graduated from West Point in 1966, received a Ph.D. in nuclear engineering from the University of Virginia, and completed a one-year fellowship at the Kennedy School of Government, Harvard University. His expertise includes project management, chemical and biological defense technology, and nuclear and missile defense systems. Jan’s Army career included leadership assignments focused on the acquisition of major defense systems, chemical-biological defense technology, missile defense technology, nuclear weapons, and developmental testing. He led two major research, development, and engineering centers, two national test ranges, and a chemical munitions storage facility.

After thirty years with the United States Army, he retired in 1996 as a Major General, and subsequently became a senior vice president and partner at the Bechtel Corporation. Jan then spent 13 years with Bechtel where he was president of Bechtel’s 5,000-person Defense and Space business (2003-2006).  Jan was Deputy Laboratory Director of the Los Alamos National Laboratory, from 2006-2009. In this capacity, he was responsible for oversight and integration of the daily operations of the laboratory with focus on safety, security, business services, environmental management, and infrastructure. Jan has served as a board member of a number of companies, including Bechtel National, Inc., Kwajalein Range Services (Chair), Bechtel Bettis, Inc., Universities Space Research Association (Chair), and the Armed Services YMCA.

read more